TMCnet News
Research and Markets: Myelofibrosis - Pipeline Review, H2 2014Research and Markets (http://www.researchandmarkets.com/research/wfqmn5/myelofibrosis) has announced the addition of the "Myelofibrosis - Pipeline Review, H2 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Myelofibrosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Myelofibrosis and special features on late-stage and discontinued projects. This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from This proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases rom company/university sites and industry-specific third party sources, put together by This team. Drug profiles/records featured in the report undergoes periodic updating following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Reasons to buy
Companies Mentioned:
For more information visit http://www.researchandmarkets.com/research/wfqmn5/myelofibrosis
|